Bellerophon Therapeutics, Inc. in its Annual meeting of shareholders held on June 1, 2022 elected Mary Ann Cloyd and Crispin Teufel to serve on the Company's board of directors for a three-year term until the Company's 2025 annual meeting of stockholders and until each of their respective successors is duly elected and qualified.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.051 USD | 0.00% | +2.00% | +37.84% |
May. 02 | North American Morning Briefing : Stock Futures -2- | DJ |
Apr. 25 | North American Morning Briefing : More Tech -2- | DJ |
1st Jan change | Capi. | |
---|---|---|
+37.84% | 624K | |
+20.12% | 126B | |
+25.25% | 119B | |
+25.56% | 27.95B | |
-19.51% | 20.5B | |
-14.36% | 17.12B | |
-15.63% | 16.1B | |
-46.67% | 14.97B | |
+11.89% | 14.84B | |
+57.74% | 14.38B |
- Stock Market
- Equities
- BLPH Stock
- News Bellerophon Therapeutics, Inc.
- Bellerophon Therapeutics, Inc. Announces New Board Appointment